Hematopoietic progenitors obtained from the bone marrow of healthy adults fail to undergo clonogenic maturation in vitro if a source of hematopoietic growth factors is not included in the culture dishes. In contrast, a fraction of similarly purified progenitors obtained from umbilical cord blood undergo clonogenic maturation even in the absence of added growth factors. We postulated that production of hematopoietic growth factors within the culture dishes containing the progenitors of umbilical cord blood origin might be responsible. We postulated further, that this production might be by non-progenitor cells co-plated along with the progenitors, or alternatively by CD34+ cells themselves, or by cells clonally derived from CD34+ cells. To test these possibilities we first assessed the effect of including in the cultures neutralizing antibody directed against various growth factors. Inclusion of anti-granulocyte macrophage colonystimulating factor (GM-CSF) and anti-interleukin-3 (IL-3) (but not anti-IL-2) significantly reduced the growth factor independence of cord blood progenitors ( P < .005 and P < .01).
Hematopoietic progenitors obtained from the bone marrow of healthy adults fail to undergo clonogenic maturation in vitro if a source of hematopoietic growth factors is not included in the culture dishes. In contrast, a fraction of similarly purified progenitors obtained from umbilical cord blood undergo clonogenic maturation even in the absence of added growth factors. We postulated that production of hematopoietic growth factors within the culture dishes containing the progenitors of umbilical cord blood origin might be responsible. We postulated further, that this production might be by non-progenitor cells co-plated along with the progenitors, or alternatively by CD34+ cells themselves, or by cells clonally derived from CD34+ cells. To test these possibilities we first assessed the effect of including in the cultures neutralizing antibody directed against various growth factors. Inclusion of anti-granulocyte macrophage colonystimulating factor (GM-CSF) and anti-interleukin-3 (IL-3) (but not anti-IL-2) significantly reduced the growth factor independence of cord blood progenitors ( P < .005 and P < .01).
EMATOPOIETIC PROGENITORS obtained from the blood or liver of early gestation human fetuses, or from umbilical cord blood, have growth factor requirements that are distinct from those of progenitors obtained from adults."' For example, a portion of fetal progenitors undergo clonal maturation in vitro in the absence of added growth factors. Also, a substantial portion of fetal progenitors undergo clonogenic maturation in the presence of factors that when used singly are not sufficient to support maturation of progenitors from adults. Examples of factors that as single agents induce clonal maturation of fetal but not adult progenitors include interleukin-6 (IL-6),' interleukin-9 (IL-9),3 interleukin-l 1 (IL-11); and erythropoietin ( e p~) .~,~ In the latter case, epo alone is sufficient to induce clonal maturation of many of the burst-forming unit-erythroid (BF'U-E) of fetal origin, while BFU-E of adult origin require, in addition to epo, a factor with erythroid burst promoting activity (BPA) such as granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), or IL-9.
The basis for these differences in growth factor requirements is not known. We postulated that production of hematopoietic growth factors within culture dishes that contain the progenitors of umbilical cord blood origin might explain these unique features. We postulated further that the cells producing such growth factors in culture might be either CD34' cells, progeny of CD34+ cells, or contaminating nonprogenitor cells co-plated with the progenitors. Alternatively, the unique features might be due to basic differences between the progenitors of adult and fetal origin themselves. Studies were designed to test these hypotheses.
H MATERIALS AND METHODS

Subjects.
Marrow was aspirated from eight healthy adult volunteers. Blood was obtained from the placental end of the cord by direct needle-puncture of the umbilical vein immediately following 11 healthy vaginal deliveries at term. The studies were performed according to protocols approved by the University of Utah InstituBlood, Vol 84, No 11 (December l), 1994: pp 3679-3684
Inclusion of both anti-GM-CSF and anti-IL-3 almost completely ablated the spontaneous colony growth ( P < .001).
Inclusion of IL-10 also reduced, in a concentration-dependent fashion, the spontaneous generation of umbilical cord blood-derived colonies. Transcripts for GM-CSF and IL-3 were detected, by reverse transcriptase-polymerase chain reaction (RT-PCR), in the CD34+ cells from cord blood and from adult marrow. When plated without added growth factors, however, the CD34+ cells of adult marrow origin failed to produce colonies, whereas 6% of cord blood CD34' cells similarly cultured did so. When these growth factor independent colonies were plucked from culture, transcripts for GM-CSF and IL-3 were identified in all. We conclude that production of GM-CSF and IL-3 occurs within culture dishes containing hematopoietic progenitors of umbilical cord origin, and that this explains some of their apparently unique features of in vitro growth.
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tional Review Board and informed consent was obtained from the participants.
Clonogenic cultures. Light density cells (sg < 1.077) were obtained by layering marrow or cord blood over Ficoll-Paque (Pharmacia Inc, Piscataway, NJ). Adherent cells were removed by incubation in plastic culture flasks for 90 minutes after which the nonadherent cells were incubated with murine antibodies directed against lymphocytes (anti-Leu-l, anti-Leu-5b. and anti-leu-12; Becton Dickinson, San Jose, CA), monocytes (anti-Leu-MS, Becton Dickinson) and mature erythroid cells (Accurate Scientific and Chemical Corp, Westbury, NY). Antibody-bound cells were removed using magnetic beads coated with goat anti-mouse antibodies (Dynal Inc. Great Neck, NY).
Cells were plated at densities of either 5 to 10 X lo3 per mL in 1 mL culture dishes or 10 to 20 per mL in 0.1 mL microtiter wells.
Cells were plated in a 1% methylcellulose mixture (Sigma Chemicals, St Louis, MO) containing 30% fetal calf serum (Hyclone Laboratories Inc, Logan, UT), 1% bovine serum albumin (Sigma), 5 X m o m B-mercaptoethanol (Eastman Kodak, Rochester, NY) and alpha MEM (Hyclone). In some experiments, recombinant human epo (Amgen, Thousand Oaks, CA), with a specific activity of > 3 X l@ Ulmg and a purity by sodium dodecyl sulfate polyacrylamide gel electrophoresis of > 99.7%, was added (2 U/mL) on initiation of the culture. In other experiments the epo was added to cultures following a 72 hour delay. 7 In some experiments IL-3 and GM-CSF (R&D Systems, Minneapolis, MN) were added at the initiation of the culture. In some experiments, neutralizing antibodies directed against GM-CSF, IL-3, if IL-2 (as a control) alone or in combinations, were included at the initiation of the cultures (R & D Systems). At a concentration of 10 pglmL, anti-GM-CSF neutralized > 99% of the biologic activity of 0.5 ng/mL recombinant GM-CSF in clonogenic assays. At a concentration of 10 pglmL, anti-IL-3 neutralized > 80% of the biologic activity of 1.25 ng/mL recombinant IL-3.
After 14 days of culture, colonies were categorized in situ as CFU-GM-derived colonies if they contained no red elements and were composed of > 50 cells. They were categorized as BFU-Ederived colonies if they were composed exclusively of red, tightly clustered aggregates, and as CFU-MIX-derived colonies if they contained red, tightly clustered aggregates plus non-red loosely arranged cells.
In other studies, CD34' cells obtained from adult marrow and from cord blood were cultured in microtiter wells, 1 to 2 cells per well, in the absence of hematopoietic growth factors (epo was added to the dishes 72 hours after culture initiation). The colonies that developed were plucked from the microtiter wells at day 14 and transferred with micropipettes into alpha MEM for RNA analysis. As controls for those studies, methylcellulose media of approximately equal volume, not containing cells, was also plucked.
Effect of IL-l0 (cytokine synthesis inhibitor) on the aut~nornous growth of hematopoietic progenitors. Three replicate experiments (each in quadruplicate) were performed in which culture dishes were incubated containing 1 X IO4 light density cord blood cells or adult marrow cells. In other studies 1 X 10' light density, non-adherent. negatively panned cord blood and adult marrow cells were plated in methylcellulose culture. No recombinant hematopoietic growth factors were added to these culture dishes. At the time of culture initiation, recombinant IL-10 (R & D Systems) was added to the dishes, in concentrations of 0, 0. I , 1 .O, or 10.0 ng/mL. and after 14 days the colonies were scored.
RNA isolation, reverse transcription, and PCR ampl$cation. Light-density cells obtained from cord blood or adult marrow were sorted according to levels of CD34 antigen expression. Cells were stained by incubation in the dark for 45 minutes at 4°C with PEcongugated anti CD34 antibody (Becton Dickinson). Staining was shown with PE-congugated anti-IgG antibody. Cells were sorted on a FACStar flow cytometer (Becton Dickinson) according to their expression levels of CD34. Sorted cells were subsequently reassessed, by FACS, for purity of CD34' cells. Of the sorted cells, > 96% were CD34+ and < 4% were LeuM5+, CD34-. lmmediately after assessing the purity of the CD34+ sorted cells they were placed in guanidinium thiocyanate for subsequent RNA extraction.
Total cellular RNA was extracted from CD34+ cells, and from the clones derived from CD34' cells, using a single-step acid guanidinium thiocyanate-phenol-chloroform method.' First strand cDNA was reverse transcribed from 100 ng of total cellular RNA with random hexamers (Boeringer Mannheim, Indianapolis, IN) using a modification of the procedure described by Sambrook et al. 'n Oligonucleotide primers that amplify a portion of the mRNA for GM-CSF." IL-3," and beta actin." respectively were chosen with the aid of the computer program OLlGO 4.0 (National Biosciences. Inc, Plymouth, MN). These primers were synthesized by the protein/ DNA Core Facility, University of Utah School of Medicine. and HPLC purified in the GRECC Core Laboratory of the Salt Lake City Veterans Administration Medical Center. Following 40 cycles of PCR amplification in the Perkin-Elmer Cetus 9600 thermocycler," 25 pL aliquots of each 50 pL reaction were electrophoresied through a 1% SeaKem Agarose gel (FMC Bioproducts, Rockland. MA) in I X Tris-AcetateEDTA stained with 0.5 pg of Ethidium bromide per milliliter of gel and running buffer at 2VDC/cm constant current. One hundred and 123 bp ladders (Life Technologies Inc, Gaithersburg, MD) were used to size the amplified products. Once the fragments were well resolved, the gels were illuminated with UV 280-nm light and photographed with type 55 positive/negative Kodak Polaroid film through a no. 15 Wratten and 2E UV filter.
Clonogenic cultures at low density. In studies designed to elucidate whether IL-3 and GM-CSF were contributed by CD34' cells or their progeny or by other differentiated cells co-plated with progenitor cells, we isolated CD34' cells from umbilical cord blood using binding of biotinylated CD34 antibody within an avidin column (Cellpro, Inc. Bothell, WA). Purified cells, 37% to 55% CD34' by FACS analysis, were plated in methylcellulose culture at a density of one cell per four wells in microtiter plates. IL-3 and GM-CSF were added to control plates, but no growth factors were added to cells plated in microtiter wells except erythropoietin, which was added after 72 hours. Colonies were categorized in situ at 14 days as described previously.
Statistical analysis. Differences in colony growth between adult and fetal samples, and between antibody containing versus antibody free groups. were assessed with a Student t test.
RESULTS
Autostimulation of GM clones derived from umbilical cord blood and attempts to ablate this with anti-GM-CSF and anti-IL-3 antibody. Light density, non-adherent, negatively panned marrow cells from adult bone marrow, stimulated with GM-CSF and IL-3, produced 56.8 ? 17.8 GM colonies per 1 O4 plated cells ( Table 1 , column 1). Essentially no colonies developed in dishes containing adult cells and no growth factors (0.6 i 0.9 GM colonies per IO4 plated cells, Table I , column 2). In contrast, umbilical cord blood cells cultured in the absence of growth factors produced 6.6 2 2.0 GM colonies per lo4 plated cells (Table I , 
column 2).
This growth in the absence of added growth factors was diminished by the inclusion of neutralizing anti-GM-CSF or anti-IL-3 antibody in the cultures (Table 1, columns 3-5) . Similarly, the inclusion of anti-GM-CSF andor anti-IL-3 antibody reduced the colony formation induced by recombinant IL-1 1 and IL-6 (Table 1, columns 6-13). In contrast, the inclusion of anti-IL-2 neutralizing antibody, as a similarly prepared control antibody, had no effect on colony growth (data not shown).
BPA-independence of BFU-E from cord blood, and attempts to ablate this with anti-GM-CSF and anti-IL-3 antibody. When epo was withheld from cultures of adult marrow for the initial 72 hours, fewer BFU-E colonies formed (3 2 1 BFU-E colonies per 5,000 plated cells) than when epo was added initially (1 5 ? 2 BFU-E colonies, P < .05, Table 2 ). Withholding epo from the culture dishes for 72 hours had no effect on CFU-GM or CFU-MIX colony formation. No colonies developed when adult marrow cells were deprived of epo for 72 hours and then grown in epo only (no added GM-CSF or IL-3). In contrast, withholding epo from fetal cultures for 72 hours had no significant effect on BFU-E colony formation (24 ? 7 BFU-E colonies/5000 plated cells vs 32 ? 10 when epo was added initially). Some BFU-E, CFU-GM, and CFU-MIX colonies developed even when no recombinant GM-CSF or IL-3 was added ( Table  2 ). The BPA-independence of cord blood progenitors was diminished by inclusion of anti-GM-CSF or anti-IL-3 in the culture dishes ( Table 3) . Inclusion of both antibodies resulted in significant reduction of the growth factor independence. Inclusion of anti-IL-2 neutralizing antibody had no effect on BFU-E colony formation (data not shown).
Effect of IL-l0 (cytokine synthesis inhibitor) on the autonomous growth of hematopoietic progenitors. Culture dishes that contained 1 X lo4 light density cord blood cells or adult marrow cells and no added growth factors developed 17 t 7 and 15 t 6 CFU-GM colonies, respectively. Inclusion of recombinant IL-10 in these culture dishes diminished colony formation in a dose-dependent fashion (Table 4) . Culture dishes containing 1 X lo3 light density, non-adherent, negatively panned cord blood cells produced 6 t 5 CFU-GM colonies (Table 5 ). Addition of IL-10 to the culture dishes had no effect on colony formation. Similarly prepared culture dishes containing adult marrow cells generated no colonies whether or not IL-l0 was included in the cultures.
GM-CSF and IL-3 mRNA in FACS-sorted CD34+ cells,
and in colonies plucked from culture of CD34' cells grown in the absence of growth factors. From three umbilical cord blood specimens, we obtained 2.5 to 3.5 X lo6 CD34+ cells, and from three adult marrow specimens 0.2 to 2.5 X IO6 CD34+ cells were obtained. RNA extracted from each of these six aliquots of CD34+ cells contained bands corre- For personal use only. on October 3, 2017. by guest www.bloodjournal.org From sponding with mRNA for GM-CSF and for IL-3 (Fig l ) .
The expected amplified product of the GM-CSF (HUMGM-CSFA) mRNA transcript" was 1 IO bp between positions 100 and 210. The expected amplified product of the IL-3
IL3
(HUMIL3A) mRNA transcript" was 116 bp between positions 85 and 201. No bands corresponding with the unintended amplification of genomic GM-CSF or IL-3 DNA were observed. CD34' cells of adult origin generated no colonies when plated in the absence of growth factors (epo was added after 72 hours). In contrast, 6% of wells (54 of 960) containing CD34' cord blood cells developed colonies (29 percent of wells contained colonies when such cells were grown with recombinant GM-CSF, IL-3, G-CSF, and epo). The colonies derived from CD34+ cord blood cells, grown in the absence of added recombinant growth factors, were plucked on day 14. The expected 3 13 bp amplified product between positions 209 and 522 of the GM-CSF (HUMGMCSFA) mRNA transcript" was observed in all colonies examined (Fig 2A) . The expected 210 bp amplified product between positions 407
and 617 of the IL-3 (HUMIL3A) mRNA transcript" was also observed in all colonies examined (Fig 2B) . The expected 141 bp amplified product between positions 226 and 367 of the beta-actin (HUMACCYBA) mRNA transcript'> was also observed in all colonies examined (Fig 2C) . No GM-CSF, IL-3 or beta-actin transcripts were identified in the control acellular cultures (data not shown). No bands corresponding with the unintended amplification of genomic GM-CSF or IL-3 DNA were observed. Clonogenic cultures at low density Experiments evaluating the capacity of cord blood CD34' cells plated at very low density, one cell per four microtiter wells, to generate colonies in the absence of growth factors except epo which was added after 72 hours are depicted in Table 6 . When plated at low density to minimize the possibility of contaminating cells or of other progenitor cells contributing growth factors to hematopoietic progenitors in culture, a certain proportion of cords blood progenitor cells continued to generate colonies (0.4% to 0.9% of CD34' cells plated) in the absence man et all observed that by including dexamethasone with cultures of human fetal progenitors fewer erythroid colonies and fewer normoblasts per colony developed. These reductions were not observed when progenitors from adults were subjected to the same conditions.' Also, we previously observed that high concentrations of epo in vitro resulted in a dose-dependent down-modulation of neutrophil production from fetal but not from adult CFU-GM.".'" A third difference between fetal and adult progenitors was observed by Emerson et aI5 and Valtieri et al,' who reported that epo alone induced erythroid burst formation from embryonic and fetal BFU-E, whereas BFU-E of adult origin required, in addition to epo. GM-CSF or IL-3. A fourth difference is that a portion of fetal progenitors undergo clonogenic maturation in the absence of added growth factors, or when stimulated with factors such as IL-I 1 that as single agents do not support maturation of progenitors from adults.'.'
The biological basis for these differences are not known but they might be important to the understanding of developmental hematopoiesis. We suspect that some of the apparent differences in fetal versus adult progenitors might be the result of production of hematopoietic growth factors within culture dishes containing the developing clones. That hypothesis was supported by our experiments demonstrating nearly total ablation of the growth factor independent colony formation of umbilical cord blood progenitors by including 3683 neutralizing anti-GM-CSF and anti-lL-3 (but not control) antibody in the cultures. The dose-dependent reduction in growth factor independent colony formation in cultured cord blood and adult marrow light density cells with the inclusion of IL-10 also seems to imply that production of growth factors occurs within the culture dishes. The lack of inhibitory effect of IL-l0 on autonomous colony formation by negatively panned cord blood progenitors indicates that contaminating cells such as macrophages were less likely to be the source of growth factors. To the contrary, this would support the hypothesis that there exist basic differences between adult marrow and cord blood progenitors and that cord blood progenitors or their progeny are responsible for the production of growth factors in the culture dishes.
The precise cellular sources of the GM-CSF and IL-3 within the culture dishes, however, are not known. We identified GM-CSF and IL-3 mRNA in the CD34' fraction of cells obtained from both adult marrow and umbilical cord blood. Production of biologically active GM-CSF and IL-3 by these cells was not assessed. The possibility remains that CD34' cells of umbilical cord blood origin produce greater quantities of GM-CSF and IL-3 than do those of adult marrow origin, and that this autocrine mechanism explains their apparent growth factor independence. Another possibility is that CD34' cells of umbilical cord blood origin are capable of generating progeny in the absence of added growth factors and that those progeny produce GM-CSF and IL-3, supporting clonal growth in a paracrine fashion. It is also possible that the CD34' fraction from umbilical cord blood includes a population of BFU-E with embryonic-fetal properties that differ substantially from progenitors in adult marrow populations, and that these differences result in the apparent differences in growth factor requirements. We judge that it is not likely that GM-CSF and IL-3 is produced exclusively by contaminating non-progenitor cells, of umbilical cord blood origin, co-plated with the CD34' cells, because we performed experiments on CD34' cells plated at very low density (0.25 celldwell) in microtiter wells. Similarly, clonal maturation observed in the absence of added growth factors 
GM-CSF
In cultures containing growth factors, CD34+ cells were plated at a density of 10' cellslmL in quadruplicate plates containing IL-3 and GM-CSF (5 nglmL each) in the media. Epo was added to all cultures (4 UImLl after 72 hours of culture.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From in these studies favors an autocrine mechanism, rather than a paracrine mechanism for the unique growth factor requirements of cord blood progenitors as the likelihood of more than one cell being co-plated in the same microtiter well was probably very low.
Monocyte/macrophage progenitors and precursors, many of which likely express CD34, were undoubtedly present in our CD34' fractions. Similarly, macrophages were undoubtedly present in the clones that we plucked from culture." Because macrophages can produce GM-CSF," it is possible that macrophages derived from CD34+ cells in culture were the cells of origin of the GM-CSF. The cells responsible for production of the IL-3 is not ~1ear.I~
The present studies do not exclude the possibility that the growth factor independence observed in a fraction of umbilical cord blood progenitors is, in part, due to the enhanced action of epo on a residual population of progenitors possessing embryonic properties such as those described in fetal liver progenitom6 Differences in growth factor requirements between adult progenitors and these embryonic progenitors could be due to intrinsic differences in epo receptor expression or in intracellular signal transduction mechanisms. Alternatively, factors within the fetal microenvironment might activate expression of certain genes, which accentuate the action of epo on this subpopulation of cord blood hematopoietic progenitors.
On the basis of the present studies, we conclude that production of GM-CSF and IL-3 occurs within culture dishes containing hematopoietic progenitors of umbilical cord origin, and that this likely explains some of their apparently unique features of in vitro clonogenic growth.
